Peripheral Neuropathy in Personal Injury and Workers' Compensation Litigation — What Attorneys Need to Know
Peripheral neuropathy — damage to the nerves outside the brain and spinal cord — is one of the most commonly encountered neurological conditions in personal injury and workers' compensation litigation. It presents in cases ranging from workplace chemical exposures and repetitive trauma to surgical complications and motor vehicle accidents. Yet despite its prevalence, peripheral neuropathy remains one of the most contested diagnoses in the courtroom, largely because its causes are numerous, its symptoms are subjective, and the electrodiagnostic testing used to confirm it requires careful interpretation by qualified specialists.
For attorneys handling neuropathy cases, the medical complexity is both a challenge and an opportunity. Understanding how peripheral neuropathy is diagnosed, what distinguishes traumatic or toxic neuropathy from common idiopathic forms, and how a neurology expert witness builds a defensible causation opinion can be the difference between a case that survives Daubert scrutiny and one that does not.
Understanding Peripheral Neuropathy: Clinical Foundations for Attorneys
Peripheral neuropathy refers to dysfunction of the peripheral nerves — the network of motor, sensory, and autonomic nerves that extend from the spinal cord to the muscles, skin, and organs throughout the body. When these nerves are damaged, patients may experience numbness, tingling, burning pain, weakness, balance difficulties, and autonomic dysfunction such as blood pressure instability or gastrointestinal symptoms.
The condition is classified along several dimensions that matter for litigation.
By distribution: Polyneuropathy affects nerves symmetrically and diffusely, typically starting in the feet and hands (a "stocking-glove" pattern). Mononeuropathy affects a single nerve — for example, carpal tunnel syndrome (median nerve) or peroneal neuropathy (common peroneal nerve at the fibular head). Mononeuropathy multiplex affects multiple individual nerves in an asymmetric pattern, often suggesting a vasculitic or inflammatory process.
By fiber type: Large fiber neuropathy affects the myelinated sensory and motor fibers, producing numbness, weakness, and abnormal reflexes that are detectable on standard electrodiagnostic testing (nerve conduction studies and electromyography). Small fiber neuropathy affects thinly myelinated and unmyelinated fibers that carry pain, temperature, and autonomic signals. Small fiber neuropathy is particularly relevant in litigation because it produces significant symptoms — burning pain, allodynia, autonomic dysfunction — but may yield normal results on standard nerve conduction studies, creating an evidentiary gap that defense counsel will exploit.
By pathophysiology: Axonal neuropathies involve direct damage to the nerve fibers themselves and are the most common type seen in toxic exposures and metabolic conditions. Demyelinating neuropathies involve damage to the myelin sheath surrounding nerve fibers and suggest inflammatory or immune-mediated processes (such as chronic inflammatory demyelinating polyneuropathy, or CIDP). The distinction matters because the temporal course, expected recovery, and differential diagnosis differ significantly between axonal and demyelinating processes.
By etiology: This is the dimension that matters most in litigation. Peripheral neuropathy has over 100 recognized causes, including diabetes mellitus (the most common cause in developed countries), alcoholism, vitamin deficiencies (B12, B1, B6, folate), autoimmune conditions, hereditary conditions (Charcot-Marie-Tooth disease), infections (HIV, Lyme disease, hepatitis C), medications (chemotherapy agents, certain antibiotics, statins), toxic exposures (heavy metals, organic solvents, pesticides), and physical trauma (compression, stretch, laceration, or ischemia). In a significant percentage of cases — estimates range from 20% to 30% — no cause is identified despite thorough evaluation, and the neuropathy is classified as idiopathic or cryptogenic.
This long list of alternative causes is precisely why causation is the central battleground in neuropathy litigation. The plaintiff must establish, through competent expert testimony, that the alleged exposure, injury, or medical negligence was the cause of the neuropathy — not diabetes, not alcohol, not aging, and not idiopathic disease.
Electrodiagnostic Testing: The Evidentiary Cornerstone
Nerve conduction studies (NCS) and electromyography (EMG) — collectively referred to as electrodiagnostic testing or EDX — are the primary objective tools for confirming and characterizing peripheral neuropathy. Understanding what these tests can and cannot prove is essential for attorneys litigating neuropathy cases.
Nerve conduction studies measure the speed and amplitude of electrical signals transmitted along peripheral nerves. Reduced conduction velocity suggests demyelination; reduced amplitude suggests axonal loss. NCS can localize the site of nerve damage (critical in compression or surgical injury cases), distinguish between axonal and demyelinating pathology, and provide objective evidence that neuropathy exists.
Electromyography involves inserting a small needle electrode into muscles to assess the electrical activity of the motor units. EMG can detect denervation — evidence that the nerve supplying a muscle has been damaged — and can help determine whether nerve injury is acute, subacute, or chronic based on the pattern of spontaneous activity and motor unit morphology.
Several issues with electrodiagnostic testing create litigation flash points.
Operator dependence. EDX testing is highly operator-dependent. The accuracy of results depends on proper electrode placement, skin temperature control, selection of appropriate nerves to test, and the clinical judgment of the examiner in interpreting borderline findings. An EDX study performed by an inexperienced technician or interpreted by a physician without fellowship training in neuromuscular medicine or clinical neurophysiology may produce unreliable results.
Small fiber neuropathy limitations. Standard NCS and EMG test large myelinated nerve fibers. They do not assess small fibers. A patient with severe small fiber neuropathy — debilitating burning pain, temperature sensation loss, and autonomic dysfunction — may have entirely normal NCS and EMG results. Confirming small fiber neuropathy requires skin punch biopsy with intraepidermal nerve fiber density (IENFD) quantification, autonomic function testing (such as quantitative sudomotor axon reflex testing, or QSART), or corneal confocal microscopy. Defense experts who point to normal NCS/EMG as evidence against neuropathy may be committing a fundamental error if small fiber involvement was the clinical concern.
Timing of testing. EDX findings evolve over time after nerve injury. Testing performed too early (within the first one to two weeks after an acute injury) may be falsely normal because Wallerian degeneration — the process by which the distal portion of a severed or severely damaged nerve degenerates — has not yet produced detectable changes. Conversely, testing performed years after an exposure or injury may show chronic changes that are difficult to date precisely. The timing of the EDX study relative to the alleged causative event is always relevant.
Pre-existing abnormalities. Many patients, particularly older individuals and those with diabetes, have pre-existing subclinical neuropathy. Baseline EDX studies are rarely available, making it difficult to determine how much of the detected neuropathy is new versus pre-existing. This is a standard defense argument, and the plaintiff's neurology expert must address it directly.
Causation Analysis: Connecting Neuropathy to the Alleged Cause
Causation is where neuropathy litigation cases are won or lost. The neurology expert must establish both general causation (the alleged agent or mechanism is capable of causing peripheral neuropathy) and specific causation (the alleged agent or mechanism did cause this particular patient's neuropathy).
Temporal relationship. The onset of neuropathy symptoms must bear a biologically plausible temporal relationship to the alleged cause. Toxic neuropathies typically develop during or within weeks to months of exposure. Traumatic neuropathies — whether from direct nerve injury, compression, or ischemia — present acutely or subacutely. A neuropathy that predates the alleged exposure by years, or that develops years after a brief, low-level exposure ended, is difficult to attribute causally.
Dose-response relationship. For toxic neuropathy claims, the expert should address whether the level and duration of exposure are consistent with the development of neuropathy based on published literature. Many chemicals cause neuropathy only at specific thresholds of exposure intensity or cumulative dose. Absent documentation of exposure levels — which is common in older workers' compensation cases — the causation opinion becomes more vulnerable.
Pattern consistency. The type and distribution of neuropathy should be consistent with the alleged cause. Hexane exposure, for example, produces a distal axonal sensorimotor polyneuropathy. Lead exposure produces a predominantly motor neuropathy with wrist drop. Surgical nerve injury produces a focal mononeuropathy in the distribution of the injured nerve. If the patient's clinical and electrodiagnostic findings do not match the expected pattern for the alleged cause, causation becomes problematic.
Exclusion of alternative causes. This is the step that defense counsel will scrutinize most aggressively. The plaintiff's neurology expert must demonstrate that a reasonable differential diagnosis was considered and that alternative causes were excluded or accounted for. A patient with diabetes, heavy alcohol use, and a workplace solvent exposure who develops polyneuropathy presents a genuine causation puzzle. The expert must explain why the exposure — rather than the diabetes or alcohol — is the more probable cause, and this explanation must rest on specific clinical reasoning, not mere temporal coincidence.
The "substantial contributing factor" standard. In many jurisdictions, the plaintiff need not prove that the alleged cause was the sole cause of the neuropathy, but rather that it was a substantial contributing factor. A neurology expert who can articulate why the neuropathy is worse than it would have been from the pre-existing condition alone — a "but for" or "aggravation" theory — may be able to support a viable causation opinion even in the presence of competing risk factors.
Workers' Compensation Neuropathy Cases: Special Considerations
Peripheral neuropathy cases arise frequently in workers' compensation, and the medicolegal framework differs in important ways from civil tort litigation.
Occupational toxic exposures. Workers in manufacturing, agriculture, painting, printing, and cleaning industries may be chronically exposed to neurotoxic solvents (n-hexane, methyl n-butyl ketone, trichloroethylene), heavy metals (lead, arsenic, mercury, thallium), and pesticides (organophosphates, carbamates). These exposures are well-documented causes of peripheral neuropathy in the medical literature, but establishing the causal link for a specific claimant requires documentation of the exposure (industrial hygiene records, OSHA logs, material safety data sheets), the clinical pattern of neuropathy, and the temporal relationship.
Repetitive trauma and compression neuropathies. Carpal tunnel syndrome is the most common work-related peripheral nerve condition, but other compression neuropathies — ulnar neuropathy at the elbow (cubital tunnel syndrome), peroneal neuropathy from prolonged kneeling or squatting, and thoracic outlet syndrome — also arise in occupational contexts. The causation analysis requires the expert to address whether the claimant's specific job duties created the biomechanical conditions for nerve compression, and whether pre-existing risk factors (diabetes, thyroid disease, obesity, anatomic variants) were contributing factors.
Vibration-induced neuropathy. Workers who use vibrating hand tools (pneumatic drills, grinders, chain saws) over prolonged periods may develop hand-arm vibration syndrome (HAVS), which includes a peripheral neuropathy component affecting the digital nerves. This diagnosis requires specific occupational history documentation and may involve specialized vascular and neurophysiological testing.
Maximum medical improvement and impairment rating. In workers' compensation cases, the treating or examining neurologist will be asked to determine when the claimant has reached maximum medical improvement (MMI) and to assign a permanent impairment rating. The American Medical Association's Guides to the Evaluation of Permanent Impairment is the standard reference in most jurisdictions, and the neurology expert should be familiar with the methodology for rating peripheral nerve impairment under the applicable edition of the Guides. Disputes over impairment ratings are common and often require expert testimony to resolve.
Return-to-work evaluations. The neurologist may also be asked to opine on the claimant's functional capacity and work restrictions. A worker with significant peripheral neuropathy affecting the hands may be unable to perform fine motor tasks; a worker with lower extremity neuropathy and balance impairment may be unable to work at heights or on uneven surfaces. These opinions must be grounded in objective clinical and electrodiagnostic findings, not solely on the claimant's subjective reports.
Common Defense Strategies in Neuropathy Litigation
Attorneys should anticipate several recurring defense arguments in peripheral neuropathy cases.
"The neuropathy is idiopathic." As noted, 20% to 30% of all peripheral neuropathies have no identifiable cause. Defense experts will argue that the plaintiff's neuropathy falls into this category and that the temporal relationship to the alleged cause is coincidental. The plaintiff's expert must demonstrate that a systematic evaluation was performed, that the clinical profile is inconsistent with idiopathic neuropathy (which is typically a slowly progressive, length-dependent, sensory-predominant process), or that the timing and pattern of symptom onset are inconsistent with an idiopathic etiology.
"Pre-existing diabetes (or alcohol, or medication) caused the neuropathy." This is the most common defense argument. The plaintiff's expert must address whether the pre-existing condition was severe enough to cause the degree of neuropathy observed, whether the temporal course is more consistent with the occupational or traumatic cause, and whether the pattern of neuropathy is atypical for the alleged pre-existing cause.
"The electrodiagnostic findings are normal or nonspecific." Defense counsel may argue that normal NCS/EMG results disprove neuropathy. As discussed, this argument fails if the clinical concern is small fiber neuropathy. The plaintiff's expert must be prepared to explain the limitations of standard electrodiagnostic testing and to present alternative objective evidence (skin biopsy, autonomic testing) when appropriate.
"The plaintiff's symptoms are subjective and exaggerated." Neuropathy symptoms — pain, numbness, tingling — are inherently subjective, and malingering or symptom magnification is a standard defense theory. The neurology expert should address the consistency of the plaintiff's reported symptoms with objective findings, the presence or absence of anatomically consistent patterns, and any standardized symptom validity measures that were administered.
"The exposure levels were too low to cause neuropathy." In toxic exposure cases, defense experts will argue that the documented or estimated exposure was below the threshold for neurotoxicity. The plaintiff's expert should address published dose-response data, the possibility of cumulative toxicity from chronic low-level exposure, and individual susceptibility factors that may lower the threshold for a given patient.
The Role of the Neurology Expert Witness in Neuropathy Cases
A qualified neurology expert witness is essential in virtually every peripheral neuropathy litigation case. The expert serves several functions.
Confirming the diagnosis. The expert reviews the clinical history, examination findings, electrodiagnostic studies, laboratory workup, and any additional testing (skin biopsy, autonomic studies, genetic testing) to confirm or refute the diagnosis of peripheral neuropathy and to characterize its type, severity, and distribution.
Establishing causation. The expert renders an opinion, within a reasonable degree of medical probability, on the cause of the neuropathy. This requires systematic differential diagnosis, exclusion of alternative causes, and application of established diagnostic criteria and published medical literature.
Addressing standard of care. In medical malpractice cases involving neuropathy — delayed diagnosis, failure to order electrodiagnostic testing, failure to identify and remove a neurotoxic medication, surgical nerve injury — the expert opines on whether the treating physician's conduct met the applicable standard of care.
Quantifying impairment and prognosis. The expert provides an assessment of the plaintiff's current functional impairment and expected clinical trajectory. Neuropathy may be static, progressive, or partially reversible depending on the cause and the extent of axonal damage versus demyelination. This opinion informs both economic damages (lost earning capacity, future medical costs) and non-economic damages (pain and suffering, loss of enjoyment of life).
Withstanding cross-examination and Daubert challenge. The expert must be prepared to defend the causation methodology, explain the limitations of electrodiagnostic testing, address alternative etiologies, and present complex neurophysiology in terms accessible to a lay jury.
How NLC Approaches Peripheral Neuropathy Litigation
At Neurology Legal Consulting, peripheral neuropathy cases are among the most frequent matters we support — across both personal injury and workers' compensation contexts. Our approach is grounded in clinical precision and evidentiary rigor.
Our panel includes board-certified neurologists with fellowship training in neuromuscular medicine and clinical neurophysiology — the subspecialties directly responsible for diagnosing and managing peripheral neuropathy in clinical practice. These are clinicians who perform and interpret electrodiagnostic studies regularly, who understand the technical limitations and nuances of NCS and EMG, and who can explain those nuances to a judge or jury without losing credibility or clarity.
For toxic neuropathy cases, we match your case with experts who have specific experience in occupational and environmental neurology and who are current on the published literature regarding dose-response relationships, exposure thresholds, and the clinical patterns produced by specific neurotoxic agents. For surgical nerve injury cases, we provide neurologists who can evaluate the mechanism of injury, the expected natural history, and the adequacy of the post-injury diagnostic workup and management.
Our case evaluation process includes a comprehensive review of all medical records and electrodiagnostic studies, identification of the specific neuropathy type and distribution, a systematic differential diagnosis addressing all plausible alternative causes, and a causation opinion grounded in peer-reviewed evidence and accepted diagnostic methodology. We provide written reports suitable for Daubert disclosure and expert testimony through deposition and trial.
Whether you are pursuing a workers' compensation claim involving chronic occupational exposure, a personal injury case arising from surgical nerve damage, or a medical malpractice claim based on failure to diagnose or treat neuropathy, NLC can provide the neurology expertise your case requires. Contact us to discuss the clinical and evidentiary merits of your peripheral neuropathy case.
This post is for informational purposes and does not constitute legal advice. Standards of care vary by jurisdiction and are subject to change as medical evidence evolves.